ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

HYPERRHO S/D MINI-DOSE
Immune-mediated blood disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

HYPERRHO S/D MINI-DOSE Rx

Generic Name and Formulations:
Rho(D) immune globulin human; 250 IU; per syringe; soln for IM inj.; preservative-free; latex-free.

Company:
Grifols Biologicals, Inc.

Therapeutic Use:

Indications for HYPERRHO S/D MINI-DOSE:

Prevention of isoimmunization of Rho(D) negative women during spontaneous or induced abortion of ≤12 weeks' gestation when mother is not sensitized to Rho(D) antigen and father is not known to be Rho(D) negative.

Adult:

Postabortion or miscarriage of up to 12 weeks gestation: 1 syringe IM within 3hrs of spontaneous or induced abortion or within 72hrs following termination of pregnancy.

Children:

Not recommended.

Contraindications:

Neonates.

Warnings/Precautions:

Contains human plasma; monitor for possible infection transmission. IgA deficiency. Pregnancy (Cat.C).

Interactions:

Avoid live vaccines within 3 months.

See Also:

HYPERRHO S/D FULL DOSE

Pharmacological Class:

Immune globulin.

Adverse Reactions:

Local or infusion reactions.

Note:

Report all infections suspected to be transmitted by HyperRHO S/D to (800) 520-2807.

How Supplied:

Full dose (Single-dose prefilled syringe)—1; Mini dose (Single-dose prefilled syringe)—10

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs